Marty Makary.
American surgeon and FDA Commissioner
- Reports this week
- 0
- Active events
- 0
- Connections
- 41
What's happening
Earlier this month
-
Presley Gerber posted about Ibogaine on Instagram while Marty Makary advised the FDA on drug approval potential amid an executive order fast-tracking psychedelic research.Some support1 report
-
Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.Some support2 reports
One to three months ago
-
Peers discussed margin pressure and cost volatility, while Marty Makary served as a high-profile expert on policy issues.Some support1 report
-
Former FDA administrator Marty Makary is involved in events where FDA actions are questioned, monitored by Nassau County legislature, and Judy Jacobs is present.Some support1 report
-
A local race in 2016 demonstrated how specific local elections can reflect broader national political trends.Some support1 report
-
The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.Well supported4 reports1 development inside
-
Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.Well supported4 reports1 development inside
Gone quiet
No new reports in 90+ days-
FDA officials are facing scrutiny after a center director approved vaccines while officials allegedly withheld crucial safety data.Some support1 report1 development inside
-
HHS manages the ongoing Ebola crisis in Africa, highlighting policy clashes between HHS and FDA.Some support1 report
-
uniQure N.V. is seeking FDA approval for a gene therapy targeting Huntington's disease amid leadership changes impacting the review process.Some support2 reports
-
Marty Makary, who was a top official leading drug policy, conducted polls on behalf of President Trump.Well supported3 reports
No events began in the chosen period. Widen it, or reset.
Around Marty Makary this week
News at the entities that move Marty Makary most-
Food and Drug Administration StructuralThe Food and Drug Administration issued an order in Maharashtra to curb the sale of spoiled food.Moves Marty Makary
-
FDA StructuralNRx Pharmaceuticals is seeking regulatory approval from the FDA for its drug candidates, NRX-100 and NRX-101.Moves Marty Makary
-
Donald Trump StructuralAI could wipe away 50% of white-collar jobs, and the US administration is avoiding regulation to compete against China.Moves Marty Makary
-
CNN OperationalPolls conducted by Ipsos track high levels of public fear regarding the risks associated with AI.Moves Marty Makary
-
National Health Service OperationalHealth spending and insurance requirements are discussed across the US, England, and Netherlands.Moves Marty Makary
-
China Mentioned togetherA Quad meeting was held in Atlanta to address concerns regarding China's economic coercion.Moves Marty Makary
Connections
The 12 strongest of 41, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Marty Makary served as a high-ranking official, including Commissioner, within the FDA.
-
Heidi Overton Structural
Heidi Overton is forecast to succeed Marty Makary as the FDA Commissioner.
-
Food and Drug Administration Structural
Marty Makary held the formal leadership role of the Food and Drug Administration Commissioner.
-
Donald Trump Structural
Marty Makary's tenure and professional function as FDA commissioner were subject to political pressure and scrutiny from the Trump administration.
-
Center for Biologics Evaluation and Research Structural
Marty Makary holds a permanent director role at the Center for Biologics Evaluation and Research.
-
National Health Service Operational
The National Health Service commissioned a review that cited Marty Makary's research.
-
Scott Gottlieb Mentioned together
Marty Makary has echoed concerns previously raised by Scott Gottlieb.
-
China Mentioned together
Marty Makary reported on the issue of unlawful Chinese vapes flooding the US market.
Show all 12 connections
-
CNN Operational
Marty Makary provided commentary on drug trials to CNN.
-
Hillary Clinton Mentioned together
The entities were co-mentioned in an article discussing how a local race reflected national political trends.
-
Department of Health & Human Services Mentioned together
No evidence of a relationship between the Department of Health & Human Services and Marty Makary was found in the provided timeline.
-
Kennedy Mentioned together
No direct evidence linking Kennedy and Marty Makary was found in the provided timeline.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
2 eventsAugust 2026
1 eventShow 2 earlier months
July 2026
1 eventJune 2026
6 events- The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.
- Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.
- FDA officials are facing scrutiny after a center director approved vaccines while officials allegedly withheld crucial safety data.
- HHS manages the ongoing Ebola crisis in Africa, highlighting policy clashes between HHS and FDA.
- uniQure N.V. is seeking FDA approval for a gene therapy targeting Huntington's disease amid leadership changes impacting the review process.
- Marty Makary, who was a top official leading drug policy, conducted polls on behalf of President Trump.